| Product Code: ETC10496709 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China AI in Drug Screening Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China AI in Drug Screening Market Revenues & Volume, 2021 & 2031F |
3.3 China AI in Drug Screening Market - Industry Life Cycle |
3.4 China AI in Drug Screening Market - Porter's Five Forces |
3.5 China AI in Drug Screening Market Revenues & Volume Share, By Market Type, 2021 & 2031F |
3.6 China AI in Drug Screening Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China AI in Drug Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 China AI in Drug Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 China AI in Drug Screening Market Revenues & Volume Share, By Deployment Mode, 2021 & 2031F |
4 China AI in Drug Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in AI technology and drug discovery research in China |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Rising prevalence of chronic diseases driving the need for efficient drug screening methods |
4.3 Market Restraints |
4.3.1 Regulatory challenges and ethical concerns surrounding the use of AI in drug screening |
4.3.2 High costs associated with AI technology implementation and maintenance |
4.3.3 Lack of skilled professionals in the field of AI and drug discovery in China |
5 China AI in Drug Screening Market Trends |
6 China AI in Drug Screening Market, By Types |
6.1 China AI in Drug Screening Market, By Market Type |
6.1.1 Overview and Analysis |
6.1.2 China AI in Drug Screening Market Revenues & Volume, By Market Type, 2021 - 2031F |
6.1.3 China AI in Drug Screening Market Revenues & Volume, By Preclinical Testing, 2021 - 2031F |
6.1.4 China AI in Drug Screening Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.1.5 China AI in Drug Screening Market Revenues & Volume, By Toxicity Prediction, 2021 - 2031F |
6.1.6 China AI in Drug Screening Market Revenues & Volume, By Virtual Screening, 2021 - 2031F |
6.2 China AI in Drug Screening Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China AI in Drug Screening Market Revenues & Volume, By Target Identification, 2021 - 2031F |
6.2.3 China AI in Drug Screening Market Revenues & Volume, By Drug Repurposing, 2021 - 2031F |
6.2.4 China AI in Drug Screening Market Revenues & Volume, By Lead Optimization, 2021 - 2031F |
6.2.5 China AI in Drug Screening Market Revenues & Volume, By Biomarker Discovery, 2021 - 2031F |
6.3 China AI in Drug Screening Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 China AI in Drug Screening Market Revenues & Volume, By Machine Learning, 2021 - 2031F |
6.3.3 China AI in Drug Screening Market Revenues & Volume, By Deep Learning, 2021 - 2031F |
6.3.4 China AI in Drug Screening Market Revenues & Volume, By Natural Language Processing (NLP), 2021 - 2031F |
6.3.5 China AI in Drug Screening Market Revenues & Volume, By Computer Vision, 2021 - 2031F |
6.4 China AI in Drug Screening Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China AI in Drug Screening Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 China AI in Drug Screening Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 China AI in Drug Screening Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 China AI in Drug Screening Market Revenues & Volume, By CROs, 2021 - 2031F |
6.5 China AI in Drug Screening Market, By Deployment Mode |
6.5.1 Overview and Analysis |
6.5.2 China AI in Drug Screening Market Revenues & Volume, By Cloud-Based, 2021 - 2031F |
6.5.3 China AI in Drug Screening Market Revenues & Volume, By On-Premises, 2021 - 2031F |
6.5.4 China AI in Drug Screening Market Revenues & Volume, By Hybrid, 2021 - 2031F |
6.5.5 China AI in Drug Screening Market Revenues & Volume, By Edge, 2021 - 2031F |
7 China AI in Drug Screening Market Import-Export Trade Statistics |
7.1 China AI in Drug Screening Market Export to Major Countries |
7.2 China AI in Drug Screening Market Imports from Major Countries |
8 China AI in Drug Screening Market Key Performance Indicators |
8.1 Research and development spending dedicated to AI technology in drug screening |
8.2 Number of partnerships and collaborations between AI companies and pharmaceutical firms |
8.3 Rate of adoption of AI-based drug screening technologies in clinical trials |
8.4 Number of patents filed for AI-driven drug discovery solutions |
8.5 Percentage increase in the accuracy and efficiency of drug screening processes due to AI implementation |
9 China AI in Drug Screening Market - Opportunity Assessment |
9.1 China AI in Drug Screening Market Opportunity Assessment, By Market Type, 2021 & 2031F |
9.2 China AI in Drug Screening Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China AI in Drug Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 China AI in Drug Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 China AI in Drug Screening Market Opportunity Assessment, By Deployment Mode, 2021 & 2031F |
10 China AI in Drug Screening Market - Competitive Landscape |
10.1 China AI in Drug Screening Market Revenue Share, By Companies, 2024 |
10.2 China AI in Drug Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here